Glucocorticoids and neuroendocrine function

F. Cavagnini, M. Croci, P. Putignano, M. L. Petroni, C. Invitti

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Recent experimental evidence supports the role of glucocorticoids in the neuroendocrine control of food intake and energy expenditure. In particular, glucocorticoids promote food consumption directly through stimulation of NPY and inhibition of CRH and melanocortin release. CRH and NPY are also functionally linked by a mutual regulation. CRH is anorexigenic when secreted acutely while it exerts the opposite effect when, upon sustained secretion, it stimulates the hypothalamo-pituitary-adrenal (HPA) axis. The orexigenic effects of glucocorticoids are counteracted by a steroid-induced rise in leptin levels that closes a regulatory loop regarding food consumption. Furthermore, glucocorticoids may alter body fat distribution, increasing truncal adiposity both directly and by inhibition of growth hormone secretion. No clearcut alterations of the HPA function are apparent in obesity as a whole. However, subtle and specific abnormalities may be noted in subsets of obese patients. Indeed, obesity, mostly visceral type, is associated with an increased cortisol clearance and 11-β hydroxysteroid dehydrogenase activity in the omental fat. In the same vein, an increased cortisol rise following a mixed meal has been observed in obese subjects. Finally, it has been proposed that adrenal incidentalomas, often characterized by enhanced cortisol secretion, might be a clinical expression of the X syndrome.

Original languageEnglish
JournalInternational Journal of Obesity
Volume24
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 2000

Fingerprint

glucocorticoids
Glucocorticoids
cortisol
Hydrocortisone
food consumption
obesity
secretion
11-beta-Hydroxysteroid Dehydrogenases
Melanocortins
Body Fat Distribution
body fat distribution
Food
hydroxysteroid dehydrogenases
Abdominal Obesity
hormone secretion
Adiposity
adiposity
Leptin
leptin
energy expenditure

Keywords

  • 11-β hydroxysteroid dehydrogenase
  • CRH
  • Food intake
  • Glucocorticoids
  • Growth hormone
  • Leptin
  • Melanocortins
  • NPY
  • Obesity

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Glucocorticoids and neuroendocrine function. / Cavagnini, F.; Croci, M.; Putignano, P.; Petroni, M. L.; Invitti, C.

In: International Journal of Obesity, Vol. 24, No. SUPPL. 2, 2000.

Research output: Contribution to journalArticle

@article{d394f05b98d747a88d0f003a3a6bd710,
title = "Glucocorticoids and neuroendocrine function",
abstract = "Recent experimental evidence supports the role of glucocorticoids in the neuroendocrine control of food intake and energy expenditure. In particular, glucocorticoids promote food consumption directly through stimulation of NPY and inhibition of CRH and melanocortin release. CRH and NPY are also functionally linked by a mutual regulation. CRH is anorexigenic when secreted acutely while it exerts the opposite effect when, upon sustained secretion, it stimulates the hypothalamo-pituitary-adrenal (HPA) axis. The orexigenic effects of glucocorticoids are counteracted by a steroid-induced rise in leptin levels that closes a regulatory loop regarding food consumption. Furthermore, glucocorticoids may alter body fat distribution, increasing truncal adiposity both directly and by inhibition of growth hormone secretion. No clearcut alterations of the HPA function are apparent in obesity as a whole. However, subtle and specific abnormalities may be noted in subsets of obese patients. Indeed, obesity, mostly visceral type, is associated with an increased cortisol clearance and 11-β hydroxysteroid dehydrogenase activity in the omental fat. In the same vein, an increased cortisol rise following a mixed meal has been observed in obese subjects. Finally, it has been proposed that adrenal incidentalomas, often characterized by enhanced cortisol secretion, might be a clinical expression of the X syndrome.",
keywords = "11-β hydroxysteroid dehydrogenase, CRH, Food intake, Glucocorticoids, Growth hormone, Leptin, Melanocortins, NPY, Obesity",
author = "F. Cavagnini and M. Croci and P. Putignano and Petroni, {M. L.} and C. Invitti",
year = "2000",
doi = "10.1038/sj/ijo/0801284",
language = "English",
volume = "24",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Glucocorticoids and neuroendocrine function

AU - Cavagnini, F.

AU - Croci, M.

AU - Putignano, P.

AU - Petroni, M. L.

AU - Invitti, C.

PY - 2000

Y1 - 2000

N2 - Recent experimental evidence supports the role of glucocorticoids in the neuroendocrine control of food intake and energy expenditure. In particular, glucocorticoids promote food consumption directly through stimulation of NPY and inhibition of CRH and melanocortin release. CRH and NPY are also functionally linked by a mutual regulation. CRH is anorexigenic when secreted acutely while it exerts the opposite effect when, upon sustained secretion, it stimulates the hypothalamo-pituitary-adrenal (HPA) axis. The orexigenic effects of glucocorticoids are counteracted by a steroid-induced rise in leptin levels that closes a regulatory loop regarding food consumption. Furthermore, glucocorticoids may alter body fat distribution, increasing truncal adiposity both directly and by inhibition of growth hormone secretion. No clearcut alterations of the HPA function are apparent in obesity as a whole. However, subtle and specific abnormalities may be noted in subsets of obese patients. Indeed, obesity, mostly visceral type, is associated with an increased cortisol clearance and 11-β hydroxysteroid dehydrogenase activity in the omental fat. In the same vein, an increased cortisol rise following a mixed meal has been observed in obese subjects. Finally, it has been proposed that adrenal incidentalomas, often characterized by enhanced cortisol secretion, might be a clinical expression of the X syndrome.

AB - Recent experimental evidence supports the role of glucocorticoids in the neuroendocrine control of food intake and energy expenditure. In particular, glucocorticoids promote food consumption directly through stimulation of NPY and inhibition of CRH and melanocortin release. CRH and NPY are also functionally linked by a mutual regulation. CRH is anorexigenic when secreted acutely while it exerts the opposite effect when, upon sustained secretion, it stimulates the hypothalamo-pituitary-adrenal (HPA) axis. The orexigenic effects of glucocorticoids are counteracted by a steroid-induced rise in leptin levels that closes a regulatory loop regarding food consumption. Furthermore, glucocorticoids may alter body fat distribution, increasing truncal adiposity both directly and by inhibition of growth hormone secretion. No clearcut alterations of the HPA function are apparent in obesity as a whole. However, subtle and specific abnormalities may be noted in subsets of obese patients. Indeed, obesity, mostly visceral type, is associated with an increased cortisol clearance and 11-β hydroxysteroid dehydrogenase activity in the omental fat. In the same vein, an increased cortisol rise following a mixed meal has been observed in obese subjects. Finally, it has been proposed that adrenal incidentalomas, often characterized by enhanced cortisol secretion, might be a clinical expression of the X syndrome.

KW - 11-β hydroxysteroid dehydrogenase

KW - CRH

KW - Food intake

KW - Glucocorticoids

KW - Growth hormone

KW - Leptin

KW - Melanocortins

KW - NPY

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=0033913461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033913461&partnerID=8YFLogxK

U2 - 10.1038/sj/ijo/0801284

DO - 10.1038/sj/ijo/0801284

M3 - Article

C2 - 10997615

AN - SCOPUS:0033913461

VL - 24

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - SUPPL. 2

ER -